Tag: medical

Retrophin to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series

SAN DIEGO, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Retrophin, Inc. (Nasdaq:RTRX) today announced that Alvin Shih, M.D., executive vice president and head of research & development, will present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series in New York City on Wednesday, September 28, 2016 at 11:05 a.m. ET. A live webcast of the…

Inc. Magazine Names PTS Diagnostics to its 2016 List of the 5,000 Fastest Growing Private Companies

INDIANAPOLIS, Sept. 14, 2016 (GLOBE NEWSWIRE) -- PTS Diagnostics, the US-based manufacturer of point-of-care biometric testing devices distributed across the globe, has been selected for an impressive sixth time to the prestigious Inc. 5000 list. For the 2016 Inc. 5000 list, PTS Diagnostics placed as the 3,772nd fastest growing private company in America based on…

SR Scales Selected by Life Care Centers of America as Preferred Provider of Portable Wheelchair Scales

TONAWANDA, N.Y., Sept. 14, 2016 (GLOBE NEWSWIRE) -- SR Instruments, a leading manufacturer of purpose-built scales for hospitals, medical facilities, and long term centers, today announced that its flagship product line, SR Scales, has been selected as the preferred provider of portable wheelchair scales for all Life Care Centers of America institutions. With over 200…

Frontier Pharma: Chronic, Acute and Neuropathic Pain – GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes: ResearchMoz

Albany,NY, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Pain, and in particular chronic pain, is a significant global health issue. While pain is not considered a disease in its own right, there is a growing body of evidence that substantiates chronic pain as a disease, rather than just as a symptom of a primary cause. In…

Miramar Labs’ miraSmooth Procedure Featured on The Rachael Ray Show

SANTA CLARA, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Miramar Labs, Inc., (OTCQB:MRLB), a global aesthetic company, announced today that its miraSmooth™ treatment was featured in the September 6th episode of “The Rachael Ray Show”, an award-winning and nationally syndicated daytime TV show. The theme of the episode, “Can 3 High-Tech Beauty Treatments Improve Your…

Carpenter Technology Announces Retirement Plan Changes

Will freeze General Retirement Plan effective December 31, 2016 Aligns retirement benefit plans for most employees WYOMISSING, Pa., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE:CRS) (the “Company”) today announced changes to retirement plans it offers to certain employees. The Company will freeze benefits accrued to eligible participants of the General Retirement Plan…

Hurco Companies, Inc. Announces Quarterly Cash Dividend

INDIANAPOLIS, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Hurco Companies, Inc. (Nasdaq:HURC), an international industrial technology company, announced today that its Board of Directors approved the payment of a cash dividend of $0.09 per share.  The dividend will be paid on October 17, 2016, to shareholders of record as of the close of business on September…

Iris Plans Receives Venture Backing From Bay Area’s Better Ventures

AUSTIN, Texas, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Iris Plans, a tech-enabled Advance Care Planning (ACP) service for people facing serious medical conditions, announced today that Better Ventures has joined the company’s seed financing round. Iris Plans has now raised its original target of $750,000 for this round and will likely increase the size of…

INC Research and CISCRP Announce Finalists for “Inspiring Hope” Ideathon

RALEIGH, N.C., Sept. 14, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, today announced…

BioXcel’s BXCL101, Receives Orphan Drug Designation from the U.S. FDA for the Treatment of Patients with Neurofibromatosis Type 2 (NF2)

BRANFORD, Conn., Sept. 13, 2016 (GLOBE NEWSWIRE) -- BioXcel, a privately held biopharmaceutical company based in Connecticut, today announced that the U. S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BXCL101 for the treatment of Neurofibromatosis Type 2 (NF2), an orphan disease with significant unmet medical need.  BXCL101 is the first…

Firsthand Technology Value Fund Discloses Top Portfolio Holdings

SAN JOSE, Calif., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of August 31, 2016 were IntraOp Medical, Pivotal Systems, QMAT, Wrightspeed, and Turn. IntraOp Medical Corp. is…

EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of Defense

WALTHAM, Mass., Sept. 13, 2016 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases and disorders of the eye, today announced that Jade Therapeutics, Inc. (“Jade”), a wholly owned subsidiary of EyeGate, has received the second year of funding…

ENT and Allergy Associates, LLP(R) Port Jefferson/East Patchogue, NY Practitioner Recognized for her Outstanding Contributions to the Field of Otolaryngology

TARRYTOWN, N.Y., Sept. 13, 2016 (GLOBE NEWSWIRE) -- The ear, nose and throat specialists and sub-specialists of ENT and Allergy Associates (ENTA)-the nation's preeminent otolaryngology practice-have long valued support offered to clinicians by the American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS). Year after year, so many of the Practice's 180+ physicians attend…
Vascular Solutions Surpasses 150,000 Successfully Reprocessed ClosureFAST® Catheters

Organovo and Collaborators Publish Data in Toxicological Sciences Demonstrating Power of 3D Bioprinted Human Liver Tissues in Modeling Drug-Induced Liver Injury Leading to Fibrosis

SAN DIEGO, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced a publication in the scientific journal, Toxicological Sciences, which demonstrates the power of Organovo’s ExViveTM Human Liver Tissue to effectively model drug-induced liver injury…

WellStar Health System expands Best Upon Request concierge service to six additional hospitals

MARIETTA, GA., Sept. 13, 2016 (GLOBE NEWSWIRE) -- It has been a big year for WellStar Health System. The organization has partnered with West Georgia Medical Center of LaGrange, Georgia, in addition to acquiring five Tenet Healthcare Corporation hospitals. Joining them in this expansion is Cincinnati-based Best Upon Request Corporate, Inc. (BEST). BEST, an on-site…

Arbutus’ Chief Scientific Officer, Dr. Michael J. Sofia, Awarded the 2016 Lasker~DeBakey Clinical Medical Research Award

VANCOUVER, British Columbia and DOYLESTOWN, Pa., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael J. Sofia, Arbutus’ Chief Scientific Officer, has been awarded the 2016 Lasker~DeBakey Clinical Medical Research Award for the development of a revolutionary treatment of hepatitis…
Miramar Labs’ CEO Interviewed on Bloomberg Radio

Farmer Bros. Co. Reports Fourth Quarter and Fiscal 2016 Financial Results

FORT WORTH, Texas, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Farmer Bros. Co. (NASDAQ:FARM) (the "Company") today reported financial results for its fourth quarter and fiscal year ended June 30, 2016. Fourth Quarter Fiscal 2016 Highlights: Net sales increased $1.6 million to $134.2 million in the fourth quarter of fiscal 2016, as compared to the prior…

AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2016

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced financial results for the quarter ended June 30, 2016. “Over the past year we’ve continued to make progress…
Left Menu Icon
Right Menu Icon